250 related articles for article (PubMed ID: 25862904)
1. Critical evaluation of a prospective study of concurrent chemoradiotherapy with S-1 for early glottic carcinoma.
Kimura K; Itoh Y; Okada T; Nakahara R; Kawamura M; Kubota S; Itoh J; Hiramatsu M; Fujimoto Y; Shibata T; Naganawa S
Anticancer Res; 2015 Apr; 35(4):2385-90. PubMed ID: 25862904
[TBL] [Abstract][Full Text] [Related]
2. Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas.
Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Hirakawa A; Naganawa S
Asian Pac J Cancer Prev; 2018 May; 19(5):1195-1199. PubMed ID: 29801401
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma.
Nonoshita T; Shioyama Y; Nakamura K; Nakashima T; Ohga S; Yoshitake T; Ohnishi K; Terashima K; Asai K; Honda H
J Radiat Res; 2010; 51(4):481-4. PubMed ID: 20601829
[TBL] [Abstract][Full Text] [Related]
4. [Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
Ikeda Y; Tsukuda M; Tanigaki Y; Yabuki K; Mitake D; Ishitoya J
Gan To Kagaku Ryoho; 2008 May; 35(5):789-92. PubMed ID: 18487914
[TBL] [Abstract][Full Text] [Related]
5. Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas: An initial analysis.
Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Naganawa S
Nagoya J Med Sci; 2017 Aug; 79(3):331-338. PubMed ID: 28878438
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
[TBL] [Abstract][Full Text] [Related]
7. Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx.
Taguchi T; Tsukuda M; Mikami Y; Horiuchi C; Ishitoya JI; Katori H
J Laryngol Otol; 2006 Jun; 120(6):478-81. PubMed ID: 16563197
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Ohashi T; Ohnishi M; Tanahashi S; Murai M
Jpn J Clin Oncol; 2011 Mar; 41(3):348-52. PubMed ID: 21109512
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer.
Nakayama M; Hayakawa K; Okamoto M; Niibe Y; Ishiyama H; Kotani S
Jpn J Clin Oncol; 2010 Oct; 40(10):921-6. PubMed ID: 20495190
[TBL] [Abstract][Full Text] [Related]
10. [Clinical phase I trial of concurrent chemo-radiotherapy with S-1 for T2NO glottic carcinoma].
Tsuji H; Nagata M; Inoue T; Minami T; Iwai H; Ohnishi S; Yukawa H; Ogura M; Yamashita T; Nagata K
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():163-6. PubMed ID: 16897995
[TBL] [Abstract][Full Text] [Related]
11. Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study.
Fesneau M; Pointreau Y; Chapet S; Martin L; Pommier P; Alfonsi M; Laguerre B; Feham N; Berger C; Garaud P; Calais G
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):154-63. PubMed ID: 19386430
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma.
Tsuji H; Kiba T; Nagata M; Inoue T; Yukawa H; Yamashita T; Shimode Y; Murata H; Nagata K; Tomoda K
Oncology; 2006; 71(5-6):369-73. PubMed ID: 17851262
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
Herchenhorn D; Dias FL; Viegas CM; Federico MH; Araújo CM; Small I; Bezerra M; Fontão K; Knust RE; Ferreira CG; Martins RG
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):696-702. PubMed ID: 20421154
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of concurrent chemoradiotherapy with S-1 administered on alternate days for elderly patients with head and neck cancer.
Kogashiwa Y; Nagafuji H; Kohno N
Anticancer Res; 2012 Sep; 32(9):4035-40. PubMed ID: 22993356
[TBL] [Abstract][Full Text] [Related]
15. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
16. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
Tahara M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or Larynx.
Taguchi T; Takahashi M; Nishimura G; Shiono O; Komatsu M; Sano D; Sakuma Y; Tanigaki Y; Kubota A; Taguri M; Hata M; Oridate N
Jpn J Clin Oncol; 2014 Dec; 44(12):1158-63. PubMed ID: 25267992
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer.
Nakata K; Sakata K; Someya M; Miura K; Hayashi J; Hori M; Takagi M; Himi T; Kondo A; Hareyama M
J Radiat Res; 2013 Jul; 54(4):679-83. PubMed ID: 23292146
[TBL] [Abstract][Full Text] [Related]
19. Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1.
Takase Y; Itoh Y; Ohtakara K; Kawamura M; Ito J; Oie Y; Ono T; Sasaki Y; Nishida A; Naganawa S
Nagoya J Med Sci; 2021 May; 83(2):251-258. PubMed ID: 34239173
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
Nonoshita T; Shioyama Y; Kunitake N; Nakamura K; Nomoto S; Ohga S; Toriya Y; Ono M; Honda H
Fukuoka Igaku Zasshi; 2009 Jan; 100(1):26-31. PubMed ID: 19378773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
